Ionis Pharmaceuticals (IONS) Misses Q4 EPS by $2.72, Revenues Beat; Offers FY21 Revenue Guidance Below Consensus
Go back to Ionis Pharmaceuticals (IONS) Misses Q4 EPS by $2.72, Revenues Beat; Offers FY21 Revenue Guidance Below Consensus| (NASDAQ: IONS) | Delayed: 75.89 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $75.89 | 52 Week High | $62.68 | |||
| Open | $75.89 | 52 Week Low | $19.59 | |||
| Day High | $75.89 | P/E | N/A | |||
| Day Low | $75.89 | EPS | $0.00 | |||
| Volume | 278 | |||||

